Radioimmunoassays of Ethinyl-norgestrienone (R-2323) and medroxyprogesterone acetate (MPA) and their clinical applicability.

MLA

Frick, J., et al. “Radioimmunoassays of Ethinyl-Norgestrienone (R-2323) and Medroxyprogesterone Acetate (MPA) and Their Clinical Applicability.” Urological Research, vol. 5, no. 2, June 1977, pp. 55–59. EBSCOhost, https://doi.org/10.1007/BF00256842.

APA

Frick, J., Bartsch, G., & Jakse, G. (1977). Radioimmunoassays of Ethinyl-norgestrienone (R-2323) and medroxyprogesterone acetate (MPA) and their clinical applicability. Urological Research, 5(2), 55–59. https://doi.org/10.1007/BF00256842

Chicago

Frick, J., G. Bartsch, and G. Jakse. 1977. “Radioimmunoassays of Ethinyl-Norgestrienone (R-2323) and Medroxyprogesterone Acetate (MPA) and Their Clinical Applicability.” Urological Research 5 (2): 55–59. doi:10.1007/BF00256842.